| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
As a genetic adjuvant, CTA improves the immunogenicity of DNA vaccines in an ADP-ribosyltransferase activity- and IL-6-dependent manner
|
Wan, Yanmin
|
|
2014
|
32 |
19 |
p. 2173-2180
8 p.
|
article
|
| 2 |
Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique
|
Campo, Joseph J.
|
|
2014
|
32 |
19 |
p. 2209-2216
8 p.
|
article
|
| 3 |
Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant
|
Quattrocchi, V.
|
|
2014
|
32 |
19 |
p. 2167-2172
6 p.
|
article
|
| 4 |
Editorial Board/Aims and Scope
|
|
|
2014
|
32 |
19 |
p. CO2-
1 p.
|
article
|
| 5 |
Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule
|
Silvestre, Bruna T.
|
|
2014
|
32 |
19 |
p. 2160-2166
7 p.
|
article
|
| 6 |
General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events
|
Dey, A.
|
|
2014
|
32 |
19 |
p. 2204-2208
5 p.
|
article
|
| 7 |
Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites
|
Finney, Olivia C.
|
|
2014
|
32 |
19 |
p. 2135-2138
4 p.
|
article
|
| 8 |
Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates
|
Scherließ, Regina
|
|
2014
|
32 |
19 |
p. 2231-2240
10 p.
|
article
|
| 9 |
Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness?
|
Thomas, Roger E.
|
|
2014
|
32 |
19 |
p. 2143-2149
7 p.
|
article
|
| 10 |
Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein
|
Almeida, Ana Paula Morais Martins
|
|
2014
|
32 |
19 |
p. 2181-2187
7 p.
|
article
|
| 11 |
Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency
|
Khurana, Surender
|
|
2014
|
32 |
19 |
p. 2188-2197
10 p.
|
article
|
| 12 |
Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults
|
Hopkins, Robert J.
|
|
2014
|
32 |
19 |
p. 2217-2224
8 p.
|
article
|
| 13 |
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults
|
Cummings, James F.
|
|
2014
|
32 |
19 |
p. 2251-2259
9 p.
|
article
|
| 14 |
Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial
|
Gavilondo, J.V.
|
|
2014
|
32 |
19 |
p. 2241-2250
10 p.
|
article
|
| 15 |
Stability of neuraminidase in inactivated influenza vaccines
|
Sultana, Ishrat
|
|
2014
|
32 |
19 |
p. 2225-2230
6 p.
|
article
|
| 16 |
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study
|
Wiemken, Timothy L.
|
|
2014
|
32 |
19 |
p. 2198-2203
6 p.
|
article
|
| 17 |
Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012
|
Larson, Heidi J.
|
|
2014
|
32 |
19 |
p. 2150-2159
10 p.
|
article
|
| 18 |
Vaccine R&D: Past performance is no guide to the future
|
Stephens, Peter
|
|
2014
|
32 |
19 |
p. 2139-2142
4 p.
|
article
|
Journal description